(DNA) medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines pipeline include INO-3107 for HPV-related recurrent respiratory papillomatosis (RRP); INO-3112 for the treatment of HPV-related Oropharyngeal...
3107.T Daiwabo Holdings Co., Ltd. 2,991.00 +1.13% 4527.T Rohto Pharmaceutical Co.,Ltd. 2,672.00 -0.21% 7917.T ZACROS Corporation 3,940.00 +1.94% 7864.T Fuji Seal International, Inc. 2,408.00 +1.22% 7716.T Nakanishi Inc. 2,590.00 +1.53% 6849.T Nihon Kohden Corporation 2,220...
5101.t the yokohama rubber company, limited 3,329.00 +0.15% 3107.t daiwabo holdings co., ltd. 2,942.50 -0.19% 6849.t nihon kohden corporation 2,129.00 -0.42% 3116.t toyota boshoku corporation 2,017.50 -0.52% 6504.t fuji electric co., ltd. 8,074.00 -3.82% ...
Requires Quote Available 97-3107B20-19SY-940 Amphenol-industrial-operations Requires Quote Requires Quote Available RoHS Compliant 30 Results Page 1 of 1Technical Resources / Inventory Search: Try Sierra IC©'s Datasheet Search, with Current and Obsolete datasheets available Free to ...
BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease. The company develops BIV201 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III cl...